Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines
Nicholas A Kennedy, Simeng Lin, James R Goodhand, Neil Chanchlani, Ben Hamilton, Claire Bewshea, Rachel Nice, Desmond Chee, JR Fraser Cummings, Aileen Fraser, Peter M Irving, Nikolaos Kamperidis, Klaartje B Kok, Christopher A Lamb, Jonathan Macdonald, Shameer J Mehta, Richard CG Pollok, Tim Raine, Philip J Smith, Ajay M Verma, Timothy J McDonald, Shaji Sebastian, Charlie W Lees, Nick Powell, Tariq Ahmad, Contributors to the CLARITY IBD study
medRxiv 2021.03.25.21254335; doi: https://doi.org/10.1101/2021.03.25.21254335